Harmony Biosciences Holdings, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 73.69%82.64%81.82%80.93%79.17%78.06%
EBT Margin -2,535.06%-23.13%12.25%23.91%29.79%26.84%
EBIT Margin -2,433.76%10.63%28.66%27.45%32.99%26.70%
EBITDA Margin -2,433.76%-23.13%11.33%41.41%22.17%20.37%
Operating Margin -2,433.76%10.63%28.66%27.45%32.99%26.70%
Net Margin -3,122.74%-39.97%11.33%41.44%22.14%16.44%
FCF Margin -1,260.80%-1.87%32.17%32.95%37.64%30.59%
Efficiency
Inventory Average 2.54M4.44M4.90M5.14M6.28M
Assets Average 266.89M430.26M553.66M742.66M905.32M
Equity Average -162.84M141.84M294.67M434.92M563.07M
Invested Capital -320.32M297.18M188.51M404.84M481.99M675.40M
Asset Utilization Ratio 0.600.710.790.780.79
Leverage & Solvency
Interest Coverage Ratio 3.626.398.0810.91
Debt to Equity -0.232.001.030.480.410.27
Debt Ratio 0.920.450.440.280.240.18
Equity Ratio -3.960.230.430.600.580.66
Times Interest Earned 3.626.398.0810.91
Valuation
Enterprise Value -24.46M1,827.91M2,258.92M2,902.19M1,385.05M1,495.26M
Market Capitalization 2,056.54M2,493.23M3,268.40M1,785.39M1,962.45M
Return Ratios
Return on Sales -19.93%-0.19%0.10%0.41%0.20%0.16%
Return on Capital Employed 0.13%0.23%0.25%0.33%0.26%
Return on Invested Capital -1.21%0.30%0.29%0.20%
Return on Assets -0.11%0.07%0.33%0.16%0.13%
Return on Equity 0.19%0.22%0.62%0.27%0.21%